AstraZeneca mulls spinning off China activities: FT
Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimize China-related risks, the Financial Times reported on Monday.
Jun 19, 2023
0
2
Anglo-Swedish drugmaker AstraZeneca could spin off its Chinese division and list it in Hong Kong to minimize China-related risks, the Financial Times reported on Monday.
Jun 19, 2023
0
2
For drugmaker Pfizer, a fortune amassed in the COVID pandemic is now paving the path to pharma nirvana: a weight loss pill worth billions.
Nov 9, 2022
0
19
Almost 500 students at China's premier college for broadcast journalists have been sent to a quarantine center after a handful of COVID-19 cases were detected in their dormitory.
Sep 11, 2022
0
34
Pfizer reported another quarter of huge revenues growth because of its COVID-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.
May 3, 2022
0
0
The COVID-19 outbreak in China's largest metropolis of Shanghai remains "extremely grim" amid an ongoing lockdown confining around 26 million people to their homes, a city official said Tuesday.
Apr 5, 2022
0
27
Last year, Indian Prime Minister Narendra Modi told the United Nations his country would make enough COVID-19 vaccines "to help all humanity." Now India is struggling to meet its own domestic needs for the shots amid a startling ...
May 22, 2021
0
2
China's drug authorities have given "conditional" approval for a second COVID-19 vaccine, Sinovac's CoronaVac jab, the pharmaceutical company said Saturday.
Feb 6, 2021
0
6
China, which has at least four coronavirus vaccine candidates in the last stage of clinical trials, said Friday it is joining an international initiative to distribute COVID-19 vaccines to countries worldwide known as COVAX, ...
Oct 9, 2020
0
3
Tunisia on Tuesday launched a contact-tracing mobile phone app that identifies and alerts users who may have had contact with others infected with the new coronavirus.
May 19, 2020
0
2
Scientists in the city at the center of China's virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease, possibly fueling conflict over technology policy that helped trigger ...
Feb 6, 2020
0
1